International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 5
September-October 2024
Indexing Partners
Analyzing Barriers to Entry in the Biopharmaceutical Sector: an Entrepreneurial Perspective
Author(s) | Khushi Satnaliwala |
---|---|
Country | India |
Abstract | The biopharmaceutical sector has experienced significant growth in recent years, driven by advancements in recombinant DNA technology and the development of innovative therapies such as therapeutic proteins, monoclonal antibodies, and gene therapies. However, establishing a successful startup in this industry has challenges, including regulatory barriers, financial constraints, and technical hurdles. This paper analyzes the key barriers to entry in the biopharmaceutical sector from an entrepreneurial perspective. The regulatory landscape is complex, with strict compliance requirements and lengthy approval processes imposed by agencies like the FDA and EMA. Constructing specialized manufacturing facilities and conducting clinical trials are capital-intensive, often requiring investments ranging from $50 million to over $400 million. Intellectual property issues, such as navigating patent rights and protecting sensitive genetic data, add further complexity. Despite these challenges, emerging markets present significant opportunities for biopharmaceutical entrepreneurs due to unmet medical needs and growing demand for cost-effective therapies tailored to local populations. Government support through grants, tax incentives, and streamlined regulatory pathways can lower barriers to entry for startups. To succeed in the biopharmaceutical landscape, companies must prioritize innovation, foster strategic partnerships, leverage regulatory expertise, adopt a patient-centric approach, and optimize their supply chains. Navigating regulatory complexities requires a deep understanding of distinct pathways and compliance requirements while securing sustainable funding from both public and private sources is crucial. In conclusion, the biopharmaceutical sector offers immense potential for entrepreneurs, but overcoming the barriers to entry requires a multifaceted approach that combines cutting-edge science, a compelling business strategy, and a clear pathway to profitability. By addressing these challenges and leveraging available resources, biopharmaceutical startups can contribute to the advancement of medical science and bring new therapies to patients worldwide. |
Keywords | Keywords: biopharmaceutical startups, barriers to entry, regulatory landscape, financial constraints, emerging markets, patient-centric approach, strategic partnerships |
Field | Biology |
Published In | Volume 6, Issue 5, September-October 2024 |
Published On | 2024-09-10 |
Cite This | Analyzing Barriers to Entry in the Biopharmaceutical Sector: an Entrepreneurial Perspective - Khushi Satnaliwala - IJFMR Volume 6, Issue 5, September-October 2024. DOI 10.36948/ijfmr.2024.v06i05.26638 |
DOI | https://doi.org/10.36948/ijfmr.2024.v06i05.26638 |
Short DOI | https://doi.org/gwfgzn |
Share this
E-ISSN 2582-2160
doi
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.